Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Needle-Safety Devices market was valued at USD 4.50 Billion in 2025 and is expected to grow at a CAGR of 5.20%, reaching USD 7.47 Billion by 2035. The market growth is driven by the increasing incidence of needlestick injuries, stringent occupational-safety regulations, rising adoption of safety-engineered syringes and needles, expanding vaccination and injectable drug-delivery programmes, and growing demand for safer blood collection and infusion procedures.
The traumatic brain injury assessment and management devices market encompasses specialized medical equipment used to detect, assess, monitor, and manage brain injuries, enabling timely diagnosis and informed clinical decision-making. These devices include computed tomography (CT) scanners, magnetic resonance imaging (MRI) systems, intracranial pressure monitors, cerebral oxygenation monitors, electroencephalography (EEG) systems, and portable neurological assessment technologies. The market was valued at USD 4.50 Billion in 2025, driven by the rising incidence of traumatic brain injuries, increasing demand for rapid neurological evaluation, expansion of emergency and critical-care facilities, and ongoing technological advancements in neuroimaging and physiological monitoring.
| Analysis Type | Factors | Example |
| Market Drivers | The principal growth driver is the increasing adoption of safety-engineered needles and syringes to prevent needlestick injuries, supported by occupational-safety requirements, healthcare-worker protection initiatives, and advances in automatic retraction and integrated shielding. | According to Terumo Corporation (2026), its globally launched K-Pack Embrace™ needle integrates one-handed safety-shield activation and supports automated pharmaceutical co-packing. |
| Market Restraints | The principal market restraint is the higher acquisition cost of safety-engineered needles compared with conventional alternatives, compounded by staff-training requirements and device-transition expenses. | According to PATH (2025), financial constraints and inadequate education continue to impede the wider implementation of injection-safety technologies. |
| Market Opportunities | The most significant market opportunity lies in expanding safety-engineered injection devices through large-scale immunization programmes, public procurement, and cost-competitive regional manufacturing. | According to UNICEF (2025), its tender for 2026-2027 supply agreements covers auto-disable syringes, insulin syringes, disposable needles, and sharps-safety boxes, creating procurement opportunities for qualified manufacturers. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Rising Adoption of Passive Safety Technologies and Occupational-Injury Prevention
The principal growth driver is the increasing adoption of safety-engineered needles and syringes to prevent needlestick injuries, supported by occupational-safety requirements, healthcare-worker protection initiatives, and advances in automatic retraction and integrated shielding. According to Terumo Corporation (2026), its globally launched K-Pack Embrace™ needle integrates one-handed safety-shield activation and supports automated pharmaceutical co-packing. Such innovations strengthen procurement incentives by reducing occupational exposure risks and potential post-exposure costs, while scalable manufacturing and integrated drug-delivery systems improve purchasing efficiency.
High Procurement Costs and Budgetary Constraints
The principal market restraint is the higher acquisition cost of safety-engineered needles compared with conventional alternatives, compounded by staff-training requirements and device-transition expenses. According to PATH (2025), financial constraints and inadequate education continue to impede the wider implementation of injection-safety technologies. Budget-constrained hospitals, particularly in price-sensitive healthcare systems, may therefore delay replacement cycles or prioritize lower upfront prices. From a financial perspective, fragmented procurement and limited economies of scale can further restrict adoption, despite the potential long-term savings from preventing occupational injuries.
Expansion of Immunization Procurement and Local Manufacturing Capacity
The most significant market opportunity lies in expanding safety-engineered injection devices through large-scale immunization programmes, public procurement, and cost-competitive regional manufacturing. According to UNICEF (2025), its tender for 2026-2027 supply agreements covers auto-disable syringes, insulin syringes, disposable needles, and sharps-safety boxes, creating procurement opportunities for qualified manufacturers. UNICEF also reports that Africa-based manufacturers are expected to supply over half of its procured syringes from 2026. Local production and bundled procurement can reduce logistics costs, improve supply resilience, and broaden access to safety devices.
Integration of Passive Safety Mechanisms with Advanced Injectable Drug-Delivery Systems
The key market trend is the shift towards integrated passive safety systems that automatically retract or shield needles, particularly in prefilled syringes and self-administered biologic therapies. According to SCHOTT Pharma and Nemera (2026), their September collaboration introduced a compatible 5.5 mL prefillable glass syringe and passive safety system for large-volume subcutaneous injections. Terumo’s January 2026 SurTract™ launch further demonstrates commercial adoption of automatic needle retraction. These integrated platforms can reduce device-integration costs and support pharmaceutical manufacturers’ investment in scalable, patient-centric injectable therapies.
Auto-Disable Syringes are Anticipated to be the Leading Product Category
Auto-disable (AD) syringes represent a key product category, supported by their built-in reuse-prevention mechanism and widespread use in routine immunization and mass vaccination programmes. According to the World Health Organization (2026), AD syringes are the only injection devices it strongly recommends for administering injectable vaccines across immunization settings. UNICEF’s 2025 procurement tender for 2026–2027 supply agreements further supports institutional demand for AD syringes.
North America remains a leading regional market, supported by established occupational-safety regulations, advanced healthcare infrastructure, and widespread adoption of safety-engineered injection devices. The Centers for Disease Control and Prevention and the Occupational Safety and Health Administration provide an established framework for preventing sharps injuries and managing occupational exposure. Meanwhile, Asia Pacific offers substantial expansion opportunities as immunization programmes, healthcare infrastructure investment, and demand for affordable injection technologies increase. These regional differences create distinct commercial opportunities: replacement-driven institutional procurement in North America and volume-led expansion across emerging Asian healthcare systems.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
BD is a global medical technology company specializing in medical devices, diagnostics, and life sciences. Its product portfolio includes safety-engineered needles, syringes, intravenous catheters, and injection systems. The company serves hospitals, laboratories, pharmaceutical manufacturers, and healthcare providers worldwide. Its focus on injection safety, device innovation, and healthcare-associated infection prevention supports its presence in the needle-safety devices market.
Terumo Corporation is a Japan-based medical technology company offering products for injection and infusion, cardiovascular care, and blood management. Its portfolio includes safety needles, syringes, and blood-collection systems designed to improve procedural safety and usability. Through its international manufacturing and distribution network, Terumo serves healthcare institutions across multiple regions, with continued product development addressing occupational exposure prevention and safer drug administration.
Nipro Corporation is a Japanese medical device manufacturer with operations spanning medical equipment, pharmaceutical packaging, and related healthcare products. Its portfolio includes syringes, needles, injection devices, and dialysis products. The company serves healthcare providers and pharmaceutical customers across international markets. Its manufacturing capabilities and focus on medical-device quality support its participation in injection delivery and safety-related product categories.
ICU Medical is a US-based medical technology company specializing in infusion therapy, vascular access, and critical-care products. Its portfolio includes infusion systems, intravenous solutions, needle-free connectors, and vascular access devices. The company serves hospitals and healthcare providers internationally, emphasizing medication delivery safety and infection prevention. Its expertise in infusion therapy and vascular access complements the broader healthcare objective of reducing procedural risks and improving patient safety.
Other key players in the market include B. Braun SE, SOL-Millennium Medical Group, and Cardinal Health
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The market comprises safety-engineered injection and vascular-access products designed to minimize accidental needlestick injuries and prevent occupational exposure to bloodborne pathogens. Demand is influenced by healthcare-worker safety requirements, increasing injection volumes, advances in needle-retraction and shielding technologies, and the adoption of safety mechanisms across drug administration, blood collection, and surgical procedures.
Market Breakup by Application
Needle safety devices are used across clinical applications involving injections, blood sampling, immunization, intravenous therapy, and diagnostic testing. Market demand is supported by the increasing use of injectable medicines, expanding vaccination programmes, growing diagnostic testing volumes, and greater emphasis on preventing sharps injuries. Device selection depends on procedural requirements, compatibility, ease of use, and safety performance.
Market Breakup by End-User
Hospitals and clinics, ambulatory surgical centres, homecare settings, and diagnostic centres use needle safety devices across diverse clinical and diagnostic procedures. Demand is shaped by patient volumes, occupational-safety protocols, procurement budgets, and the growing administration of injectable therapies outside traditional hospital settings. Increasing emphasis on infection prevention and safe clinical workflows further supports adoption.
Market Breakup by Country
Regional market development is influenced by healthcare infrastructure, occupational-safety regulations, immunization coverage, medical-device procurement practices, and access to advanced injection technologies. North America and Europe benefit from established healthcare systems and safety requirements, while Asia Pacific offers expansion opportunities through growing healthcare investment and injection volumes. Market adoption across Latin America and the Middle East and Africa depends partly on affordability, supply-chain capacity, and healthcare-system development.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.